SynthesisVaccine2018

Substance use patterns of HVTN phase I clinical trial participants: Enrollment, risk reduction counseling and retention.

Arame Thiam-Diouf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.